Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone/fentanyl era: A prospective randomized control study
The efficacy of celiac plexus neurolysis (CPN) with EUS guidance has not been confirmed in the era of developed opioids. The aim of this study was to evaluate the efficacy of EUS-guided CPN (EUS-CPN) for patients with pancreatic cancer-associated pain to compare medication using oxycodone and/or fentanyl with and without EUS-CPN.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Yoshihide Kanno, Shinsuke Koshita, Kaori Masu, Takahisa Ogawa, Hiroaki Kusunose, Toji Murabayashi, Toshitaka Sakai, Fumisato Kozakai, Kei Ito Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Endoscopy | Fentanyl | Gastroenterology | Neurology | Oxycodone | OxyContin | Pain | Pancreas | Pancreatic Cancer | Study